)
Edge
Extra Everything: The Story of Chipotle
Chipotle's story from a single restaurant to a nationwide chain, through crisis and turnaround, built on one of the strongest models in the industry.
Trinity Biotech
Trinity Biotech (TRIB) investor relations material
Trinity Biotech Q1 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q1 2026 earnings summary18 Jun, 2026
Executive summary
Received orders for over 2 million TrinScreen HIV tests, to be fulfilled in Q3 2026, supporting revenue and profitability targets.
Demand for rapid HIV diagnostics rebounded after 2025 disruptions in international aid funding.
Commercial scale-up of outsourced UniGold HIV production underway, expected to improve gross margin, EBITDA, and cash flow in Q3 2026.
Development pipeline advancing, including CGM+ and other innovation programs for long-term growth.
Financial highlights
Q1 2026 revenue rose 43% year-over-year to $10.8m, driven by rapid HIV and haemoglobin product sales.
Gross margin improved to 35.4% from 25.2% year-over-year; gross profit reached $3.8m, up from $1.9m.
Net loss narrowed to $4.4m from $8.8m in Q1 2025.
Adjusted EBITDA was negative $1.1m, a significant improvement from negative $4.0m in Q1 2025.
Outlook and guidance
Orders and manufacturing scale-up reinforce confidence in achieving 2026 revenue and profitability goals.
Commercial scale-up of outsourced manufacturing expected to be substantially complete in Q3 2026.
Continued focus on innovation and new product development to support long-term growth.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Trinity Biotech
- Flexible $25M equity facility offers capital but poses major dilution risk for shareholders.TRIB
Registration filing3 Jun 2026 - Up to 33.8M ADSs may be sold for $25M, supporting operations but increasing dilution risk.TRIBRegistration filing13 May 2026
- Debt conversion enables up to 167.95M new ADSs, causing dilution but reducing liabilities.TRIBRegistration filing13 May 2026
- Revenue fell and net loss widened, but gross margin and adjusted EBITDA improved.TRIBQ4 20251 May 2026
- Up to $25M in equity financing via ADS offering supports diagnostics growth amid high leverage and Nasdaq risks.TRIBRegistration filing5 Mar 2026
- Q2 revenue up 14%, Point-of-Care sales surged 119%, and CGM development advanced toward pivotal trials.TRIBQ2 20241 Feb 2026
- Q3 revenue up 3%, Point-of-Care up 60%, and profitability initiatives progressing.TRIBQ3 202413 Jan 2026
- Revenue and margins declined in Q1 2025, but a strong rebound is expected in Q2.TRIBQ1 202523 Dec 2025
- Revenue declined and losses narrowed in Q2 2025 amid restructuring and funding uncertainty.TRIBQ2 202523 Dec 2025
Next Trinity Biotech earnings date
Q2 202614 Aug, 2026
Trinity Biotech
Next Trinity Biotech earnings date
Q2 202614 Aug, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
Related articles
)
)
Frequently asked questions
Explore our global coverage